Kentucky has long carried one of the highest burdens of colorectal cancer in the nation. For too many families, it is a diagnosis that comes too late and with too few effective treatment options.

Stool DNA testing climbed sharply after the pandemic began while colonoscopy and fecal immunochemical test use fell, a study of nearly 25 million privately insured Blue Cross Blue Shield beneficiaries ...